Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells. (A) Primary cells were photographed by light micrographs and CK7 (green) and Vimentin (red) expression was determined by Immunofluorescence. PI (blue) staining shows the nuclei, magnification of 200Ă. (B) and (C) The sequence of R248Q p53-coding region in primary cells. (D) Expression of Fn14 in four HGSOC cells was determined by western blot. (E) CCK-8 assay was performed to detect IC50 of CDDP in HGSOC cells. (TIF 2666 kb
Figure S2. Expression of MSC stem-like markers CD44, CD73, and CD105 was analyzed by RT-PCR in three...
Figure S1. G245C and R273H reduced IR-induced apoptosis and weakened cell cycle arrest. (A) The port...
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Figure S5. Fn14 could reduce the formation of Mdm2-p53-R248Q-Hsp90. (A)-(B) Statistical data of West...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...
Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...
A plasmid carrying FMN1 was transfected into NSCLC U-1810 cells for 24 h, for which Lipofectamine-on...
Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
Additional file 1: Supplemental Figure 1. Confirmation of p53, PAX2 and PAX8 expression in murine ov...
Figure S3. p53 and p21 inhibition reduces and enhances CaSki EGFP and Kpnβ1-EGFP cell sensitivity to...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
Figure S2. Expression of MSC stem-like markers CD44, CD73, and CD105 was analyzed by RT-PCR in three...
Figure S1. G245C and R273H reduced IR-induced apoptosis and weakened cell cycle arrest. (A) The port...
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Figure S5. Fn14 could reduce the formation of Mdm2-p53-R248Q-Hsp90. (A)-(B) Statistical data of West...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...
Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...
A plasmid carrying FMN1 was transfected into NSCLC U-1810 cells for 24 h, for which Lipofectamine-on...
Figure S1. Dose-dependent response to carboplatin was tested in SK-OV-3GFP control cells and compare...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
Additional file 1: Supplemental Figure 1. Confirmation of p53, PAX2 and PAX8 expression in murine ov...
Figure S3. p53 and p21 inhibition reduces and enhances CaSki EGFP and Kpnβ1-EGFP cell sensitivity to...
Table S2. Changes in protein expression levels for each studied cancer stem cell marker following tr...
Figure S2. Expression of MSC stem-like markers CD44, CD73, and CD105 was analyzed by RT-PCR in three...
Figure S1. G245C and R273H reduced IR-induced apoptosis and weakened cell cycle arrest. (A) The port...
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...